Evidence map›Paper›PMID 31165039›Full record

ReviewFrontiers in oncology2019

Radiomics in Glioblastoma: Current Status and Challenges Facing Clinical Implementation.

Ahmad Chaddad, Michael Jonathan Kucharczyk, Paul Daniel, Siham Sabri, Bertrand J Jean-Claude, Tamim Niazi, Bassam Abdulkarim

Registry-linked trialAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06492486 (Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow), which is not on this map. Cited by 107 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06492486 phase2recruitingnot on this mapstarted 2026, after this paper: background citation

Glioma Adaptive Radiotherapy With Development of an Artificial Intelligence Workflow

TypeinterventionalSponsorTata Memorial CentreRan2026 to 2028Enrolled60ConditionsDiffuse Glioma, Glioblastoma, Adaptive Radiotherapy, Artificial IntelligenceArmsAdaptive radiotherapy
3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ahmad ChaddadDivision of Radiation Oncology, Department of Oncology, McGill University, Montreal, QC, Canada.
Michael Jonathan KucharczykDivision of Radiation Oncology, Department of Oncology, McGill University, Montreal, QC, Canada.
Paul DanielDivision of Radiation Oncology, Department of Oncology, McGill University, Montreal, QC, Canada.
Siham SabriDepartment of Pathology, McGill University, Montreal, QC, Canada.
Bertrand J Jean-ClaudeResearch Institute of the McGill University Health Centre, Glen Site, Montreal, QC, Canada.
Tamim NiaziDivision of Radiation Oncology, Department of Oncology, McGill University, Montreal, QC, Canada.
Bassam AbdulkarimDivision of Radiation Oncology, Department of Oncology, McGill University, Montreal, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiomics analysis has had remarkable progress along with advances in medical imaging, most notability in central nervous system malignancies. Radiomics refers to the extraction of a large number of quantitative features that describe the intensity, texture and geometrical characteristics attributed to the tumor radiographic data. These features have been used to build predictive models for diagnosis, prognosis, and therapeutic response. Such models are being combined with clinical, biological, genetics and proteomic features to enhance reproducibility. Broadly, the four steps necessary for radiomic analysis are: (1) image acquisition, (2) segmentation or labeling, (3) feature extraction, and (4) statistical analysis. Major methodological challenges remain prior to clinical implementation. Essential steps include: adoption of an optimized standard imaging process, establishing a common criterion for performing segmentation, fully automated extraction of radiomic features without redundancy, and robust statistical modeling validated in the prospective setting. This review walks through these steps in detail, as it pertains to high grade gliomas. The impact on precision medicine will be discussed, as well as the challenges facing clinical implementation of radiomic in the current management of glioblastoma.

Indexed as

braincancerdiagnosisglioblastomagliomaMRIradiomics

Identifiers

PMID31165039
PMCPMC6536622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.